A pathway in quiescent cells that controls p27Kip1 stability, subcellular localization, and tumor suppression

181Citations
Citations of this article
134Readers
Mendeley users who have this article in their library.

Abstract

We have created two knock-in mouse models to study the mechanisms that regulate p27 in normal cells and cause misregulation of p27 in tumors: p27 S10A, in which Ser10 is mutated to Ala; and p27CK-, in which point mutations abrogate the ability of p27 to bind cyclins and CDKs. These two mutant alleles identify steps in a pathway that controls the proteasomal degradation of p27 uniquely in quiescent cells: Dephosphorylation of p27 on Ser10 inhibits p27 nuclear export and promotes its assembly into cyclin-CDK complexes, which is, in turn, necessary for p27 turnover. We further show that Ras-dependent lung tumorigenesis is associated with increased phosphorylation on Ser10 and cytoplasmic mislocalization of p27. Indeed, we find that p27S10A is refractory to Ras-induced cytoplasmic translocation and that p27S10A mice are tumor resistant. Thus, phosphorylation of p27 on Ser10 is an important event in the regulation of the tumor suppressor function of p27. © 2006 by Cold Spring Harbor Laboratory Press.

Cite

CITATION STYLE

APA

Besson, A., Gurian-West, M., Chen, X., Kelly-Spratt, K. S., Kemp, C. J., & Roberts, J. M. (2006). A pathway in quiescent cells that controls p27Kip1 stability, subcellular localization, and tumor suppression. Genes and Development, 20(1), 47–64. https://doi.org/10.1101/gad.1384406

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free